Enterome vs Genelux

Enterome logo

Enterome

Delivering the promise of immunotherapy

49 employees · est. 2011 · Paris, France

VS
Genelux logo

Genelux

34 employees · est. 2001 · Westlake Village, United Sta...

Genelux is the older company (2011 vs 2001).

Side-by-Side Comparison

Enterome Genelux
Founded
2011 2001 older
Headquarters
Paris, France Westlake Village, United States
Employees
49 34
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Venture round Post-IPO Equity
Total Funding
$175.80M $98.98M
Funding Rounds
9 5
Services
Development of off-the-shelf cancer immunotherapy treatments Development of oncolytic immunotherapy, Clinical trial management, Expanded access programs
Target Customers
Patients with B cell malignancies, Glioblastoma, adrenal tumors, and colorectal cancer Cancer patients, Healthcare professionals, Clinical researchers
Taxonomy
ImmunotherapyBiopharmaceuticalsDrug DiscoveryOncoMimicsCancer TreatmentImmunomodulatory Drugs +9 Oncolytic ImmunotherapySolid TumorsCancer TreatmentClinical-stage BiotechViral TherapyImmunotherapies +4
Website
enterome.com genelux.com
Enterome logo

About Enterome

Enterome is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in France. It focuses on delivering the promise of immunotherapy through the development of breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. The company's unique approach to d...

Genelux logo

About Genelux

Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, and Health Care industries, focusing on oncolytic immunotherapy to improve patient outcomes in cases o...

Also comparing in this category

Comparing more than these two?

Get Enterome, Genelux and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Enterome compare?

A PDF of Enterome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Enterome was founded in 2011, based in Paris, France, with 49 employees. Enterome is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in France. It focuses on delivering the promise of immunotherapy through the development of breakthrough immuno. Genelux was founded in 2001, based in Westlake Village, United States, with 34 employees. Genelux Corporation (NASDAQ: GNLX) is a late clinical-stage biotechnology firm founded in 2001 and based in the United States. The company operates at the forefront of the Biopharma, Biotechnology, an.
Enterome has raised $175.80M and Genelux $98.98M. Latest stage: Enterome Venture round, Genelux Post-IPO Equity.
Both work in Biopharma, Biotechnology and Health Care and list cancer treatment, clinical-stage biotech and immunotherapies among their focus areas.

Compare Enterome with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Enterome on 7 Jun 2025, and Genelux on 2 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes